Annual Peptide Cycling Plan: Quarterly Rotation, Seasonal Adjustments, and Budget Planning

Most peptide users operate reactively — starting a protocol when motivated, stopping when life gets busy, restarting with a different stack after reading new information. This approach produces unpredictable results, accumulates unnecessary costs, and misses the biological leverage available when peptide use is deliberately synchronized with seasonal physiology.

An annual peptide cycling plan treats the year as a single coherent protocol. Each quarter has specific goals aligned with seasonal biology, with planned transitions, blood work checkpoints, and deload periods that prevent receptor fatigue. The result is meaningfully better outcomes and a more sustainable practice than ad hoc use.

The Annual Framework: Four Seasonal Phases

The year divides into four logical peptide phases that map cleanly onto biological and lifestyle seasons:

Q1: Winter Phase (January–March) — Immune maintenance, sleep optimization, bulk-phase anabolism

Q2: Spring Phase (April–June) — Immune recalibration, skin prep, transition to cutting

Q3: Summer Phase (July–September) — Performance support, photoprotection, injury prevention, active season

Q4: Fall Phase (October–December) — Immune prep for coming season, circadian recalibration, body composition assessment

Each phase has its primary peptides, secondary additions, deload weeks, and blood work windows built in. This is not a rigid prescription — it's a framework you adapt to your specific goals and priorities.

Q1 Winter Phase (January–March): Bulk and Deep Recovery

The longest, darkest quarter is the ideal environment for the most aggressive anabolic support of the year.

Primary peptides:

• CJC-1295 (no DAC) 100 mcg + Ipamorelin 200–300 mcg pre-bed daily
• Morning GH pulse optional (CJC-1295 100 mcg + Ipamorelin 100 mcg)
• DSIP 300–500 mcg pre-bed as needed for sleep optimization

Secondary peptides:

• BPC-157 250 mcg maintenance 3–4x/week (connective tissue support for high-volume winter training)
• TA-1 1 mg 1–2x/week immune maintenance

Q1 deload: Plan one deload week in mid-February — the midpoint of the winter training block. This coincides naturally with a training deload and resets receptor sensitivity for the final push through March.

Q1 blood work: IGF-1, fasting glucose, fasting insulin, testosterone, CBC, CMP in early January (beginning of phase) and early April (end of phase).

Q1 goal markers: 2–4 lb lean mass gain, measurable improvement in 1RM performance on primary lifts, sleep quality score 7+ average.

Q2 Spring Phase (April–June): Transition and Skin Prep

Spring requires the most significant protocol adjustment of the year. The immune focus shifts from maintenance to recalibration. Training transitions toward higher volume and cardiovascular activity. The cutting phase begins.

Primary peptides:

• AOD-9604 250 mcg fasted morning (add in April for fat mobilization during transition to deficit)
• CJC-1295 100 mcg + Ipamorelin 200 mcg pre-bed (continue from winter, taper to once-daily if adding AOD)
• GHK-Cu topical 2x daily (begin in April, ramp up as UV exposure increases through May and June)

Secondary peptides:

• TA-1 1 mg 3x/week for 8 weeks (April through May) — spring immune course to address allergy season
• LL-37 150 mcg 3x/week concurrent with TA-1 for allergy season respiratory support
• GHK-Cu injectable 2–4 mg 3x/week (optional for those with specific skin goals)

Q2 deload: One deload week in mid-May, coinciding with a training deload at the transition from strength-focused training to higher-volume conditioning work.

Q2 blood work: Spot check IGF-1 and fasting glucose in early May (6 weeks after Q1 end-of-phase draw). Full panel in early July.

Q2 goal markers: 2–4 lb fat loss, improvement in skin texture and firmness (measurable by skin elasticity assessment or subjective quality rating), allergy symptom reduction compared to previous spring.

Q3 Summer Phase (July–September): Performance and Protection

Summer is the highest-activity quarter. Training volume and intensity peak. UV exposure peaks. Social events and schedule variability are at their highest, creating compliance challenges.

Primary peptides:

• BPC-157 500 mcg daily (increase to daily during peak athletic activity period)
• TB-500 2 mg 2x/week for the first 4 weeks of July (loading), then 1x/week maintenance through September
• GHK-Cu topical 2x daily (continue from spring through summer)

Secondary peptides:

• CJC-1295 + Ipamorelin pre-bed (continue, but can reduce to 5 days/week to accommodate social schedule variability)
• Collagen peptides 15 g + 250 mg vitamin C pre-workout daily (structural support for high-load summer activity)

Q3 deload: One deload week in mid-August — the midpoint of the summer athletic peak. This also serves as a mental recharge before the final summer push.

Q3 blood work: None required mid-quarter if Q2 blood work was clean. If any Q2 markers were trending abnormal, add a spot check in August.

Q3 goal markers: Zero significant injuries during peak athletic season, maintained or reduced body fat percentage, skin quality improvement measured against spring baseline.

Q4 Fall Phase (October–December): Immune Prep and Annual Assessment

Fall is both the most critical immune window and the natural end-of-year assessment period. This quarter front-loads immune investment that protects through winter and includes the year's most comprehensive blood work draw.

Primary peptides:

• TA-1 1–1.5 mg 3x/week (October through November — the most intensive TA-1 course of the year)
• LL-37 150 mcg 3x/week (October through November, concurrent with TA-1)
• Epithalon 5–10 mg nightly for 10–20 days (one annual course in October or November)

Secondary peptides:

• CJC-1295 + Ipamorelin pre-bed (restart if cycling off during summer; ramp back up for winter bulk transition)
• DSIP as needed during the November–December holiday stress period

Q4 deload: One deload week in early December — before holiday schedule disruption peaks and before ramping into the Q1 winter protocol.

Q4 blood work (Annual comprehensive panel):

• All markers from Q1 panel
• Add: Cortisol (AM), DHEA-S, TSH + free T4, lipid panel, HbA1c, hsCRP
• This is the year's most complete assessment — it informs the Q1 protocol planning

Q4 goal markers: Fewer upper respiratory infections than the previous year, healthy IGF-1 in reference range, energy and sleep maintaining at 7+ through the historically difficult November–December period.

Annual Deload Calendar

Deload weeks are non-negotiable in a year-round protocol. Plan them in advance:

| Quarter | Deload Week | |---------|------------| | Q1 | Mid-February | | Q2 | Mid-May | | Q3 | Mid-August | | Q4 | Early December |

This creates four deload weeks across the year, each spaced approximately 8–10 weeks apart — the optimal window for GH secretagogue receptor resensitization.

Annual Blood Work Schedule

| When | What | |------|------| | Early January | Full panel: IGF-1, glucose, insulin, T, CBC, CMP, vitamin D | | Early May (spot) | IGF-1, fasting glucose, fasting insulin | | Early July | IGF-1, full basic panel | | Early November (annual) | Comprehensive panel including cortisol, DHEA-S, lipids, HbA1c |

Four blood draws per year, with two comprehensive and two spot checks, provides enough data to catch any concerning trends while not creating unnecessary cost or burden.

Annual Budget Planning

Peptide costs vary significantly by source, but planning for an annual budget prevents unexpected expenses. A representative annual cost estimate for the full protocol above:

Core daily compounds (CJC-1295 + Ipamorelin year-round, BPC-157 seasonal): Approximately $80–150/month depending on source and doses used. Annualized: $960–$1,800.

Seasonal additions (TA-1, LL-37, AOD-9604, TB-500): Typically $50–100 per compound per course. Four seasonal additions at two courses each: $400–$800/year.

One-off annual compounds (Epithalon, DSIP as needed): $50–150/year.

Blood work (if not covered by insurance): $200–$500/year for four draws depending on panel depth and lab used.

Total estimated annual investment: $1,600–$3,250

This can be significantly reduced by prioritizing the two or three compounds most aligned with your primary goals and deferring the rest.

Adapting the Plan to Your Priorities

Not everyone needs the full protocol. A simplified annual plan for those new to peptide cycling:

Core year-round: CJC-1295 + Ipamorelin pre-bed daily (5 days/week), with scheduled Q1/Q2/Q3/Q4 deload weeks.

Add one seasonal compound per quarter:

• Q1: DSIP for winter sleep
• Q2: TA-1 for spring allergy season
• Q3: BPC-157 for summer activity
• Q4: TA-1 again for fall immune prep

This simpler version costs significantly less, requires fewer injections, and is far more manageable for most people while still capturing the major annual benefits of seasonal synchronization.

For full seasonal protocols, read spring, summer, fall, and winter individual protocol guides. For how to start if you're new, see the 30-day peptide challenge.

Frequently Asked Questions

Q: Is it necessary to follow seasonal protocols or can I just run the same stack year-round? A single year-round stack ignores meaningful seasonal biology — immune demands, UV exposure, training phases, and hormonal rhythms all vary significantly across the year. You'll get better outcomes from a seasonally informed protocol, even a simplified one.

Q: How do I track all of this without it becoming overwhelming? Use a simple spreadsheet or dedicated supplement/peptide tracking app. Track three things daily: dose administered, sleep quality (1–10), and energy on waking (1–10). Review monthly. Detailed multi-marker tracking is only needed for formal quarterly assessments.

Q: What if my goals change mid-year? The annual plan is a framework, not a contract. If your priority shifts from body composition to injury recovery in month six, adjust the protocol to reflect that. The seasonal and deload structure remains useful regardless of specific goal changes.

Q: Can I do this plan if I travel frequently? Yes, with preparation. Keep peptides in an insulated travel case with ice packs for transit. Lyophilized (unreconstituted) peptides are significantly more travel-friendly. Some experienced users reconstitute peptides at their destination to minimize travel risk.

Q: What's the most important single thing to do if I can only commit to one aspect of this plan? Schedule your blood work. Without data on IGF-1, fasting glucose, and key health markers, you cannot know whether your protocol is safe and effective. Blood work first, protocol optimization second.